Targeted proteomics for absolute quantification of glucose transporter 1 in mammalian brain cells using liquid chromatography-mass spectrometry

• We developed an LC-MS/MS method to quantify GLUT1 in rodent and human cells. • GLUT1 signature decapeptide (TFDEIASGFR) is specific, and not found in other GLUTs. • LC-MS/MS had better GLUT1 sensitivity than immunoblots. • iPSC-derived brain endothelial cells have higher expression than cell lines. • GLUT1 level decreases during differentiation into astrocytes and endothelial cells. Glucose represents a major source of energy for mammalian brains. Its uptake is tributary to a functional glucose transporter (GLUT1) expression at the blood-brain barrier (BBB). However, detecting and quantifying GLUT1 at the protein level using antibodies-based methods can be challenging. In this study, we have described an analytical method (using liquid-chromatography mass-spectrometry (LC-MS/MS)) to provide a specific and absolute quantification of GLUT1 in human and non-human cells. We identified a specific peptide signature for GLUT1 (TFDEIASGFR), with a retention time of 1.53 min with three distinct MRM transitions (571.8 > 894.3, 571.8 > 537.2 and 571.8 > 650.3 m/z ratios respectively). Following optimization, we compared the GLUT1 protein expression of our method versus immunoblot and concluded that our method was superior in terms of sensitivity (LLOQ=0.78ng/mL vs. 3.125μg/lane), better dynamic range (0.78–200ng/mL versus 3.125–25μg/lane) and better linearity (R2 = 0.999 versus R2 = 0.929) than the immunoblots counterpart. Furthermore, we used such a method to provide absolute GLUT1 quantification in various brain endothelial cells, showing differences in protein expression. Finally, we also used this method to assess changes in GLUT1 protein levels during the differentiation of induced pluripotent stem cells (iPSCs) into astrocyte-like cells (iAstros) and brain microvascular endothelial cell-like cells (iBMECs). Taken together, we have developed and optimized a proteomic method for the absolute quantification of GLUT1 in mammalian cells, which allows an alternative method for protein quantification independent of the antibody-based ones.

Authors

Institutions

Publication Details

Journal
Journal of Chromatography Open
Published
2024-12-13
DOI
https://doi.org/10.1016/j.jcoa.2024.100198
Citations
2
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.65
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted proteomics for absolute quantification of glucose transporter 1 in mammalian brain cells using liquid chromatography-mass spectrometry

Iqra Pervaiz, Dhaval Patel, Abraham Al‐Ahmad, Ulrich Bickel et al.
2 citations
Journal of Chromatography Open
Diet and metabolism studies
0.65
article

Targeted proteomics for absolute quantification of glucose transporter 1 in mammalian brain cells using liquid chromatography-mass spectrometry

Iqra Pervaiz, Dhaval Patel, Abraham Al‐Ahmad, Ulrich Bickel, Yash Mehta
article en
2 citations

Abstract

• We developed an LC-MS/MS method to quantify GLUT1 in rodent and human cells. • GLUT1 signature decapeptide (TFDEIASGFR) is specific, and not found in other GLUTs. • LC-MS/MS had better GLUT1 sensitivity than immunoblots. • iPSC-derived brain endothelial cells have higher expression than cell lines. • GLUT1 level decreases during differentiation into astrocytes and endothelial cells. Glucose represents a major source of energy for mammalian brains. Its uptake is tributary to a functional glucose transporter (GLUT1) expression at the blood-brain barrier (BBB). However, detecting and quantifying GLUT1 at the protein level using antibodies-based methods can be challenging. In this study, we have described an analytical method (using liquid-chromatography mass-spectrometry (LC-MS/MS)) to provide a specific and absolute quantification of GLUT1 in human and non-human cells. We identified a specific peptide signature for GLUT1 (TFDEIASGFR), with a retention time of 1.53 min with three distinct MRM transitions (571.8 > 894.3, 571.8 > 537.2 and 571.8 > 650.3 m/z ratios respectively). Following optimization, we compared the GLUT1 protein expression of our method versus immunoblot and concluded that our method was superior in terms of sensitivity (LLOQ=0.78ng/mL vs. 3.125μg/lane), better dynamic range (0.78–200ng/mL versus 3.125–25μg/lane) and better linearity (R2 = 0.999 versus R2 = 0.929) than the immunoblots counterpart. Furthermore, we used such a method to provide absolute GLUT1 quantification in various brain endothelial cells, showing differences in protein expression. Finally, we also used this method to assess changes in GLUT1 protein levels during the differentiation of induced pluripotent stem cells (iPSCs) into astrocyte-like cells (iAstros) and brain microvascular endothelial cell-like cells (iBMECs). Taken together, we have developed and optimized a proteomic method for the absolute quantification of GLUT1 in mammalian cells, which allows an alternative method for protein quantification independent of the antibody-based ones.

Journal of Chromatography OpenVol. 7
Texas Tech University (US), Texas Tech University Health Sciences Center (US)
Zero hunger
Openalex Percentile: Top 27%
Diet and metabolism studies
0.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.